Optiver Holding B.V. Evotec Se Transaction History

Optiver Holding B.V.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 09, 2024	SELL	$6.89 - $11.4 $270,797 - $448,054	-39,303 Reduced 48.64%	41,507 $324,000
Q4 2023 Feb 13, 2024	BUY	$8.33 - $11.89 $582,566 - $831,539	69,936 Added 643.15%	80,810 $947,000
Q3 2023 Nov 13, 2023	SELL	$9.63 - $13.36 $222,279 - $308,375	-23,082 Reduced 67.98%	10,874 $107,000
Q2 2023 Aug 10, 2023	BUY	$8.95 - $12.48 $52,634 - $73,394	5,881 Added 20.95%	33,956 $383,000
Q1 2023 May 11, 2023	BUY	$8.11 - $10.53 $53,517 - $69,487	6,599 Added 30.73%	28,075 $293,000
Q4 2022 Feb 10, 2023	BUY	$7.8 - $9.85 $167,512 - $211,538	21,476 New	21,476 $173,000
Q2 2022 Aug 10, 2022	BUY	$10.78 - $15.5 $1.76 Million - $2.53 Million	162,934 Added 7084.09%	165,234 $1.98 Million
Q1 2022 May 16, 2022	BUY	$12.93 - $23.46 $29,739 - $53,958	2,300 New	2,300 $35,000

2.69M

Ticker EVO
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 353,904,992
Market Cap $1.26B
Description
Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as diabetes and complications of diabetes, fibrosis, infectious diseases, CNS diseases, oncology, pain and inflammation, immunology, rare di...

Get notified when there are updates to the investment portfolio of Optiver Holding B.V., based on Form 13F filings with the SEC.

Stay updated on Optiver Holding B.V. with notifications on news.